RPRX
$57.16-0.82%
as of close, Oct 2, 2026
☾ AH $57.16 -0.82%
Royalty Pharma plcStock · Health CareNasdaq Composite 0.05%Russell 1000 0.03%Russell 3000 0.03%MSCI World 0.02%MSCI ACWI 0.02%
Royalty Pharma plc returns by year
As of market close, Oct 2, 2026
Royalty Pharma plc returns by year (2021–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $38.64 | $57.16 | 2.0% | +50.0% | |
| 2025 | $25.51 | $38.64 | 3.8% | +55.3% | |
| 2024 | $28.09 | $25.51 | 2.8% | -6.4% | |
| 2023 | $39.52 | $28.09 | 1.8% | -27.1% | |
| 2022 | $39.85 | $39.52 | 1.8% | +1.0% | |
| 2021 | $50.05 | $39.85 | 1.3% | -19.1% |
- Annualized
- +4.9%
- 2021–2026
- Average year
- +0.7%
- 5 full years
- Best year
- +55.3%
- 2025
- Worst year
- -27.1%
- 2023
- Positive years
- 2/5
- 40% up
Annualized (CAGR)
+4.9%
2021–2026
Average year
+0.7%
5 full years
Best year
+55.3%
2025
Worst year
-27.1%
2023
Positive years
2/5
40% up
Total return by period#
Annual
-40%-20%0%20%40%
2021-19%'21
2022+0.99%'22
2023-27%'23
2024-6.4%'24
2025+55%'25
2026+50%'26
Methodology#
Total returns, dividends reinvested, measured on RPRX. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Royalty Pharma plc's average annual return?
- Since 2021, Royalty Pharma plc (RPRX) has returned about 4.9% a year (the compound annual growth rate) and an average calendar-year return of 0.7%.
- What were Royalty Pharma plc's best and worst years?
- Over 2021–2026, the best year was 2025 (+55.3%) and the worst was 2023 (-27.1%).
- How often is Royalty Pharma plc up in a year?
- 2 of the 5 full years since 2021 were positive — about 40% of the time.
More on Royalty Pharma plc
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100